2023
Scientific evidence supporting the newly developed one-health labeling tool “Med-Index”: an umbrella systematic review on health benefits of mediterranean diet principles and adherence in a planeterranean perspective
Zupo R, Castellana F, Piscitelli P, Crupi P, Desantis A, Greco E, Severino F, Pulimeno M, Guazzini A, Kyriakides T, Vasiliou V, Trichopoulou A, Soldati L, La Vecchia C, De Gaetano G, Donati M, Colao A, Miani A, Corbo F, Clodoveo M. Scientific evidence supporting the newly developed one-health labeling tool “Med-Index”: an umbrella systematic review on health benefits of mediterranean diet principles and adherence in a planeterranean perspective. Journal Of Translational Medicine 2023, 21: 755. PMID: 37885010, PMCID: PMC10601192, DOI: 10.1186/s12967-023-04618-1.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesDiabetes MellitusDiet, MediterraneanHumansOne HealthReproducibility of ResultsConceptsMediterranean diet principlesSystematic reviewAge-related chronic diseasesUmbrella systematic reviewHealth benefitsScientific evidenceRenal healthResultsA totalClinical trialsLiver healthChronic diseasesEligible reviewsObservational studyMedDiet patternEligible publicationsPremature mortalityHealth outcomesPubMed databaseIndependent investigatorsRCT designNeurological disordersObservational designSignificant associationMedDietHealthy nutrition
2001
Development and Application of a Genotypic AZT Resistance Assay: Quantitative Assessment of the Resistance Profile of Clinical Samples and the Relative Predictive Ability of a Resistance Index.
Kyriakides TC, Heimer RR. Development and Application of a Genotypic AZT Resistance Assay: Quantitative Assessment of the Resistance Profile of Clinical Samples and the Relative Predictive Ability of a Resistance Index. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 211. PMID: 11694826, DOI: 10.1097/00042560-200111010-00002.Peer-Reviewed Original ResearchConceptsViral loadCD4 countResistance indexAZT resistanceResistance profilesBaseline viral loadHIV disease progressionLigase chain reaction assayMonths of treatmentWild-type HIV-1Resistance assaysAntiretroviral therapyDisease progressionSurrogate markerChain reaction assaysHIV-1PatientsAZTPredictive abilityClinical samplesReaction assaysCountAssaysRelative predictive abilityFurther support